학술논문
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, January 2024, 196)
Subject
Language
English
ISSN
18790852
09598049
09598049